Active, Not Recruiting
Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma
NCT06478212
- Conditions
- IDH1-mutant Glioma, IDH2-mutant Glioma
- Locations
-
- University of California Los Angeles Los Angeles, California, United States
- University of Miami Miami, Florida, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States